1 |
Yang, Y. L., S. Y. Chang, H. C. Teng, Y. S. Liu, T. C. Lee, L. Y. Chuang, J. Y. Guh, F. R. Chang, T. N. Liao, J. S. Huang, J. H. Yeh, W. T. Chang, M. Y. Hung, C. J. Wang, T. A. Chiang, C. Y. Hung, and T. J. Hung. 2008. Safflower extract: a novel renal fibrosis antagonist that functions by suppressing autocrine TGF-beta. J. Cell Biochem. 104, 908-919
DOI
ScienceOn
|
2 |
Ohba, K, Y. Miyata, S. Kanda, S. Koga, T. Hayashi, and H. Kanetake. 2005. Expression of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and plasminogen activator inhibitors in patients with renal cell carcinoma: correlation with tumor associated macrophage and prognosis. J. Urol. 174, 461-465
DOI
ScienceOn
|
3 |
Perrella, M. A, C. M. Hsieh, W. S. Lee, S. Shieh, J. C. Tsai, C. Patterson, C. J. Lowenstein, N. C. Long, E. Haber, S. Shore, and M. E. Lee. 1996. Arrest of endotoxin-induced hypotension by transforming growth factor beta1. Proc. Natl. A cad. Sci. USA 93, 2054-2059
DOI
ScienceOn
|
4 |
Ricardo, S. D., H. van Goor, and A. A. Eddy. 2008. Macrophage diversity in renal injury and repair. J. Clin. Invest. 118, 3522-3530
DOI
ScienceOn
|
5 |
Sasaki, H, T. Hosokawa, M. Sawada, and K. Ando. 1973. Isolation and structure of ascofuranone and ascofranoC antibiotics with hypolipidemic activity. J. Antibiot. (Tokyo) 26, 676-680
DOI
|
6 |
Sawdey, M. S. and D. J. Loskutoff. 1991. Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-alpha, and transforming
growth factor-beta. J. Clin. Invest. 88, 1346-1353
DOI
|
7 |
Wickert, L., N. Chatain, K. Kruschinsky, and A. M. Gressner. 2007. Glucocorticoids activate TGF-beta induced PAI-1 and CTGF expression in rat hepatocytes. Comp. Hepatol. 6, 5
DOI
ScienceOn
|
8 |
Yamaguchi, N., S. Jesmin, S. Zaedi, N. Shimojo, S. Maeda, S. Gando, A. Koyama, and T. Miyauchi. 2006. Time-dependent expression of renal vaso-regulatory molecules in LPS-induced endotoxemia in rat. Peptides 27, 2258-2270
DOI
ScienceOn
|
9 |
Yamamoto, K, T. Shimokawa, H. Yi, K. Isobe, T. Kojima, D. J. Loskutoff, and H. Saito. 2002. Aging accelerates endotoxin-induced thrombosis : increased responses of plasminogen activator inhibitor-1 and lipopolysaccharide signaling with aging. Am. J. Pathol. 161, 1805-1814
DOI
ScienceOn
|
10 |
Kutz, S. M., C. E. Higgins, R. Samarakoon, S. P. Higgins, R. R. Allen, 1. Qi, and P. J. Higgins. 2006. TGF-beta 1-induced P AI-1 expression is E box/USF-dependent and requires EGFR signaling. Exp. Cell Res. 312, 1093-1105
DOI
ScienceOn
|
11 |
Lam, S., R. N. van der Geest, N. A. Verhagen, M. R. Daha, and C. van Kooten. 2004. Secretion of collagen type IV by human renal fibroblasts is increased by high glucose via a TGF-beta-independent pathway. Nephrol. Dial. Transplant 19, 1694-1701
DOI
ScienceOn
|
12 |
Leyland, H., J. Gentry, M. J. Arthur, and R. C. Benyon. 1996. The plasminogen-activating system in hepatic stellate cells. Hepatology 24, 1172-1178
DOI
ScienceOn
|
13 |
Li, G., Q. Xie, Y. Shi, D. Li, M. Zhang, S. Jiang, H. Zhou, H. Lu, and Y. Jin. 2006. Inhibition of connective tissue growth factor by siRNA prevents liver fibrosis in rats. J. Gene Med. 8, 889-900
DOI
ScienceOn
|
14 |
Magae, J., J. Hayasaki, Y. Matsuda, M. Hotta, T. Hosokawa, S. Suzuki, K. Nagai, K. Ando, and G. Tamura. 1988. Antitumor and antimetastatic activity of an antibiotic, ascofuranone, and activation of phagocytes. J. Antibiot. (Tokyo) 41, 959-965
DOI
|
15 |
Magae, J., T. Hosokawa, K. Ando, K. Nagai, and G. Tamura. 1982. Antitumor protective property of an isoprenoid antibiotic, ascofuranone. J. Antibiot. (Tokyo) 35, 1547-1552
DOI
ScienceOn
|
16 |
Fang, J., C. Xia, Z. Cao, J. Z. Zheng, E. Reed, and B. H. Jiang. 2005. Apigenin inhibits VEGF and HIF-1 expression via PI3K/ AKT/p7OS6K1 and HDM2/p53 pathways. FASEB J. 19, 342-353
DOI
ScienceOn
|
17 |
Sung, M. J., M. Davaatseren, W. Kim, S. K. Park, S. H. Kim, H. J. Hur, M. S. Kim, Y. S. Kim, and D. Y. Kwon. 2009. Vitisin A suppresses LPS-induced NO production by inhibiting ERK p38, and NF-kappaB activation in RAW 264.7 cells. Int. Immunopharmacol. 9, 319-323
DOI
ScienceOn
|
18 |
Nawata, Y., K Ando, G. Tamura, K. Arima, and Y. litaka. 1969. The molecular structure of ascochlorin. J. Antibiot. (Tokyo) 22, 511-512
DOI
|
19 |
Derynck, R. and Y. E. Zhang. 2003. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425, 577-584
DOI
ScienceOn
|
20 |
Fogo, A. B. 2003. Renal fibrosis: not just PAI-1 in the sky. J. Clin. Invest. 112, 326-328
DOI
ScienceOn
|
21 |
Garcia-Lazaro, J. F., F. Thieringer, S. Luth, P. Czochra, E. Meyer, I. B. Renteria, P. R. Galle, A W. Lohse, J. Herkel, and S. Kanzler. 2005. Hepatic over-expression of TGF-beta1 promotes LPS-induced inflammatory cytokine secretion by liver cells and endotoxemic shock. Immunol. Lett. 101, 217-222
DOI
ScienceOn
|
22 |
Higuchi, C., Y. Tanihata, H. Nishimura, T. Naito, and T. Sanaka. 2005. Effects of glucose and plasminogen activator inhibitor-Ion collagen metabolism in the peritoneum. Ther. Apher. Dial. 9, 173-181
DOI
ScienceOn
|
23 |
Hong, S., K. K. Park, J. Magae, K. Ando, T. S. Lee, T. K. Kwon, J. Y. Kwak, C. H. Kim, and Y. C. Chang. 2005. Ascochlorin inhibits matrix metalloproteinase-9 expression by suppressing activator protein-I-mediated gene expression through the ERK1/2 signaling pathway: inhibitory effects of ascochlorin on the invasion of renal carcinoma cells. J. BioI. Chem. 280, 25202-25209
DOI
ScienceOn
|
24 |
Cho, H. J., J. H. Kang, J. Y. Kwak T. S. Lee, I. S. Lee, N. G. Park, H Nakajima, J. Magae, and Y. C. Chang. 2007. Ascofuranone suppresses PMA-mediated matrix metalloproteinase-9 gene activation through the Ras/Raf/MEK/ERK- and ApI-dependent mechanisms. Carcinogenesis 28, 1104-1110
DOI
ScienceOn
|
25 |
Hosokawa, T., M. Sawada, K. Ando, and G. Tamura. 1981. Alteration of cholesterol metabolism by 4-O-methylasco-chlorin in rats. Lipids 16, 433-438
DOI
ScienceOn
|
26 |
Imail, K, A. Takeshita and S. Hanazawa. 2000. Transforming growth factor-beta inhibits lipopolysaccharide-stimulated expression of inflammatory cytokines in mouse macrophages through downregulation of activation protein 1 and CD14 receptor expression. Infect. Immun. 68, 2418-2423
DOI
ScienceOn
|
27 |
Ahn, J. D., R. Morishita, Y. Kaneda, H. J. Kim, Y. D. Kim, H. J. Lee, K. U. Lee, J. Y. Park, Y. H. Kim, K. K. Park, Y. C. Chang, K. H. Yoon, H. S. Kwon, K. G. Park, and I. K. Lee. 2004. Transcription factor decoy for AP-1 reduces mesangial
cell proliferation and extracellular matrix production in vitro and in vivo. Gene. Ther. 11, 916-923
DOI
ScienceOn
|
28 |
Cho, H. J., J. H. Kang, T. Kim, K. K. Park, C. H. Kim, I. S. Lee, K. S. Min, J. Magae, H. Nakajima, Y. S. Bae, and Y. C. Chang. 2009. Suppression of PAI-1 expression through inhibition of the EGFR-mediated signaling cascade in rat kidney fibroblast by ascofuranone. J. Cell Biochem. 107, 335-344
DOI
ScienceOn
|